Abstract
Tumor necrosis factor (TNF) is a proinflammatory cytokine implicated in pathogenesis of multiple autoimmune and inflammatory diseases. Anti-TNF therapy has revolutionized the therapeutic paradigms of autoimmune diseases and became one of the most successful examples of the clinical use of monoclonal antibodies. Currently, anti-TNF therapy is used by millions of patients worldwide. At the moment, fully human anti-TNF antibody Adalimumab is the best-selling anti-cytokine drug in the world. Here, we present a story about a highly potent anti-TNF monoclonal antibody initially characterized more than 20 years ago and further developed into chimeric and humanized versions. We present comparative analysis of this antibody with Infliximab and Adalimumab.
Keywords:
TNF; humanized antibodies; recombinant antibodies; tumor necrosis factor.
Publication types
-
Comparative Study
-
Historical Article
MeSH terms
-
Adalimumab / biosynthesis*
-
Adalimumab / isolation & purification
-
Adalimumab / pharmacology
-
Animals
-
Anti-Inflammatory Agents, Non-Steroidal
-
Antibodies, Monoclonal / biosynthesis*
-
Antibodies, Monoclonal / history
-
Antibodies, Monoclonal / isolation & purification
-
Antibodies, Monoclonal / pharmacology
-
Antibodies, Monoclonal, Humanized / biosynthesis*
-
Antibodies, Monoclonal, Humanized / history
-
Antibodies, Monoclonal, Humanized / isolation & purification
-
Antibodies, Monoclonal, Humanized / pharmacology
-
Arthritis, Rheumatoid / drug therapy*
-
Arthritis, Rheumatoid / genetics
-
Arthritis, Rheumatoid / immunology
-
Arthritis, Rheumatoid / pathology
-
Cloning, Molecular
-
Gene Expression
-
History, 20th Century
-
History, 21st Century
-
Humans
-
Infliximab / biosynthesis*
-
Infliximab / isolation & purification
-
Infliximab / pharmacology
-
Mice
-
Psoriasis / drug therapy
-
Psoriasis / genetics
-
Psoriasis / immunology
-
Psoriasis / pathology
-
Spondylitis, Ankylosing / drug therapy
-
Spondylitis, Ankylosing / genetics
-
Spondylitis, Ankylosing / immunology
-
Spondylitis, Ankylosing / pathology
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
-
Tumor Necrosis Factor-alpha / genetics
-
Tumor Necrosis Factor-alpha / immunology
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Tumor Necrosis Factor-alpha
-
Infliximab
-
Adalimumab